OKAIF (EvokAI Creative Labs) Debt-to-Revenue : N/A (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

EvokAI Creative Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.13 Mil. EvokAI Creative Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.71 Mil. EvokAI Creative Labs's annualized Revenue for the quarter that ended in Sep. 2024 was $0.00 Mil.

EvokAI Creative Labs Debt-to-Revenue Historical Data

The historical data trend for EvokAI Creative Labs's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs Debt-to-Revenue Chart

EvokAI Creative Labs Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Revenue

N/A

EvokAI Creative Labs Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Revenue	Get a 7-Day Free Trial						N/A	N/A	N/A	N/A	N/A

Competitive Comparison of EvokAI Creative Labs's Debt-to-Revenue

For the Health Information Services subindustry, EvokAI Creative Labs's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EvokAI Creative Labs's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

EvokAI Creative Labs Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

EvokAI Creative Labs's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.109	+	0.678)	/	N/A
	=	N/A

EvokAI Creative Labs's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.133	+	0.708)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.

EvokAI Creative Labs Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

EvokAI Creative Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

OKAI:Canada

Address

609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3

Website

https://www.evokailabs.com

EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.